NCT07032038View on ClinicalTrials.gov

First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

July 31, 2027

Conditions
Sensorineural Hearing LossPresbyacusisAuditory Neuropathy
Interventions
DRUG

Otic neural progenitors

Advanced Cell Therapy - tissue engineered product

DEVICE

cochlear implantation

cochlear implant

Trial Locations (3)

Unknown

University Hospitals Birmingham, Birmingham

Cambridge University Hospital, Cambridge

Guy's and St Thomas' Trust, London

Sponsors

Lead Sponsor

Rinri Therapeutics
All Listed Sponsors
collaborator

King's College London

OTHER

lead

Rinri Therapeutics

INDUSTRY

NCT07032038 - First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant | Biotech Hunter | Biotech Hunter